Bioxytran (BIXT) Revenue (QoQ) (2010 - 2018)
Bioxytran (BIXT) Revenue (QoQ) (2010 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Bioxytran | 2.52 Mn | 2.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 52.52% |
| Mar 31, 2018 | -58.63% |
| Dec 31, 2017 | -71.25% |
| Sep 30, 2017 | 183.69% |
| Jun 30, 2017 | 430.82% |
| Mar 31, 2017 | -87.22% |
| Dec 31, 2016 | -42.46% |
| Sep 30, 2016 | 81.81% |
| Jun 30, 2016 | 76.46% |
| Mar 31, 2016 | 101.52% |
| Dec 31, 2015 | -1,969.36% |
| Sep 30, 2015 | 86.50% |
| Jun 30, 2015 | -4.94% |
| Mar 31, 2015 | 617.22% |
| Dec 31, 2014 | -129.11% |
| Sep 30, 2014 | 9.66% |
| Jun 30, 2014 | -81.84% |
| Mar 31, 2014 | 40.36% |
| Dec 31, 2013 | 166.55% |
| Sep 30, 2013 | -43.69% |